Hurried Provider Communication, Low Patient Self-Efficacy Contribute to Medication Nonadherence in SLE
Researchers assessed the modifiable factors associated with persistent medication adherence among patients with SLE.
Diagnosis & Disease Information
Patients With SLE With Residual Disease Activity May Qualify for Novel Treatment
Researchers studied disease activity state in patients with SLE to quantify the need for new therapies.
COVID-19 Vaccines Not Associated With Increased Risk for SLE Flares
The aim of the study was to evaluate the occurrence of SLE flares after COVID-19 vaccination.
Lilly Ends Baricitinib Lupus Program, Provides Update on Atopic Dermatitis sNDA
Based on efficacy results from 2 phase 3 studies, Lilly has decided to discontinue development of baricitinib for lupus.
Increasing Lupus Clinical Trial Participation Among Black Women: Addressing Racism Through Communication and Community Engagement
Using Critical Race Theory, lead study author Rodlescia S. Sneed, PhD, MPH, and team assess the impact of racism on the representation of Black women with systemic lupus erythematosus in clinical trials, and highlight the need for interventions in this area.
Saphnelo Approved for Systemic Lupus Erythematosus
The Food and Drug Administration (FDA) has approved Saphnelo (anifrolumab-fnia) for the treatment of adults with moderate to severe systemic lupus erythematosus who are receiving standard therapy. Type I interferons (IFNs) play a role in the pathogenesis of systemic lupus erythematosus (SLE). Anifrolumab-fnia, a human immunoglobulin G1 kappa monoclonal antibody, binds to subunit 1 of…
Persistent Low-Moderate Thrombocytopenia May Predict Outcomes in Antiphospholipid Syndrome
Using a large cohort over a period of 38 years, the researchers assessed thrombocytopenia and other clinical variables as predictors of outcomes in patients with antiphospholipid syndrome.
Addressing Health Disparities in Lupus Care and Management
In light of Arthritis and Lupus Awareness Month 2021, Rosalind Ramsey-Goldman, MD, and Candace Feldman, MD, take us on a deep dive into the existing health disparities, including in race/ethnicity and socioeconomic status, in lupus care and management.
- Loading...
Loading...
Loading... 
Loading...